Company intelligence / Profile preview

futuresTHRIVE

Darien, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Initial validation in an NSF-funded study (n=100) showed tScreen achieved 87% agreement with the Pediatric Symptom Checklist, the gold standard. The tool is live commercially and in clinical use, enabling early detection and large-scale data collection for pediatric mental health.

Therapeutic areas: Psychiatry
Modalities: DeviceDigital health technologyArtificial intelligence-based assessment
Industry: Digital Health Medical Devices

Partnerships

OmniScience (licensed the Vivo AI platform; joint research and technology development for precision digital mental health screening)

Beyond the preview

Go deeper on futuresTHRIVE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on futuresTHRIVE.

Explore the full profile